181 related articles for article (PubMed ID: 28980094)
1. Podocalyxin as a major pluripotent marker and novel keratan sulfate proteoglycan in human embryonic and induced pluripotent stem cells.
Toyoda H; Nagai Y; Kojima A; Kinoshita-Toyoda A
Glycoconj J; 2017 Dec; 34(6):817-823. PubMed ID: 28980094
[TBL] [Abstract][Full Text] [Related]
2. Podocalyxin as a major pluripotent marker and novel keratan sulfate proteoglycan in human embryonic and induced pluripotent stem cells.
Toyoda H; Nagai Y; Kojima A; Kinoshita-Toyoda A
Glycoconj J; 2017 Apr; 34(2):139-145. PubMed ID: 28078490
[TBL] [Abstract][Full Text] [Related]
3. Glycomics of human embryonic stem cells and human induced pluripotent stem cells.
Furukawa JI; Okada K; Shinohara Y
Glycoconj J; 2017 Dec; 34(6):807-815. PubMed ID: 29150735
[TBL] [Abstract][Full Text] [Related]
4. A novel antibody for human induced pluripotent stem cells and embryonic stem cells recognizes a type of keratan sulfate lacking oversulfated structures.
Kawabe K; Tateyama D; Toyoda H; Kawasaki N; Hashii N; Nakao H; Matsumoto S; Nonaka M; Matsumura H; Hirose Y; Morita A; Katayama M; Sakuma M; Kawasaki N; Furue MK; Kawasaki T
Glycobiology; 2013 Mar; 23(3):322-36. PubMed ID: 23154990
[TBL] [Abstract][Full Text] [Related]
5. The TRA-1-60 and TRA-1-81 human pluripotent stem cell markers are expressed on podocalyxin in embryonal carcinoma.
Schopperle WM; DeWolf WC
Stem Cells; 2007 Mar; 25(3):723-30. PubMed ID: 17124010
[TBL] [Abstract][Full Text] [Related]
6. Podocalyxin is a glycoprotein ligand of the human pluripotent stem cell-specific probe rBC2LCN.
Tateno H; Matsushima A; Hiemori K; Onuma Y; Ito Y; Hasehira K; Nishimura K; Ohtaka M; Takayasu S; Nakanishi M; Ikehara Y; Nakanishi M; Ohnuma K; Chan T; Toyoda M; Akutsu H; Umezawa A; Asashima M; Hirabayashi J
Stem Cells Transl Med; 2013 Apr; 2(4):265-73. PubMed ID: 23526252
[TBL] [Abstract][Full Text] [Related]
7. The Universal 3D3 Antibody of Human PODXL Is Pluripotent Cytotoxic, and Identifies a Residual Population After Extended Differentiation of Pluripotent Stem Cells.
Kang L; Yao C; Khodadadi-Jamayran A; Xu W; Zhang R; Banerjee NS; Chang CW; Chow LT; Townes T; Hu K
Stem Cells Dev; 2016 Apr; 25(7):556-68. PubMed ID: 26886504
[TBL] [Abstract][Full Text] [Related]
8. Glycan Epitopes on 201B7 Human-Induced Pluripotent Stem Cells Using R-10G and R-17F Marker Antibodies.
Nagai Y; Nakao H; Kojima A; Komatsubara Y; Ohta Y; Kawasaki N; Kawasaki N; Toyoda H; Kawasaki T
Biomolecules; 2021 Mar; 11(4):. PubMed ID: 33805466
[TBL] [Abstract][Full Text] [Related]
9. Glycomics of human embryonic stem cells and human induced pluripotent stem cells.
Furukawa J; Okada K; Shinohara Y
Glycoconj J; 2016 Oct; 33(5):707-15. PubMed ID: 27318474
[TBL] [Abstract][Full Text] [Related]
10. Comparative proteomic analysis of human somatic cells, induced pluripotent stem cells, and embryonic stem cells.
Kim SY; Kim MJ; Jung H; Kim WK; Kwon SO; Son MJ; Jang IS; Choi JS; Park SG; Park BC; Han YM; Lee SC; Cho YS; Bae KH
Stem Cells Dev; 2012 May; 21(8):1272-86. PubMed ID: 21787230
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies specific for podocalyxin expressed on human induced pluripotent stem cells.
Watanabe T; Kakuta J; Saito S; Hasehira K; Kiyoi K; Imai T; Tateno H
Biochem Biophys Res Commun; 2020 Nov; 532(4):647-654. PubMed ID: 32912628
[TBL] [Abstract][Full Text] [Related]
12. In vitro generation of megakaryocytes and platelets from human embryonic stem cells and induced pluripotent stem cells.
Takayama N; Eto K
Methods Mol Biol; 2012; 788():205-17. PubMed ID: 22130710
[TBL] [Abstract][Full Text] [Related]
13. BMP10 as a potent inducer of trophoblast differentiation in human embryonic and induced pluripotent stem cells.
Lichtner B; Knaus P; Lehrach H; Adjaye J
Biomaterials; 2013 Dec; 34(38):9789-802. PubMed ID: 24070570
[TBL] [Abstract][Full Text] [Related]
14. Membrane permeability of the human pluripotent stem cells to Me₂SO, glycerol and 1,2-propanediol.
Xu Y; Zhang L; Xu J; Wei Y; Xu X
Arch Biochem Biophys; 2014 May; 550-551():67-76. PubMed ID: 24780243
[TBL] [Abstract][Full Text] [Related]
15. The human cancer and stem cell marker podocalyxin interacts with the glucose-3-transporter in malignant pluripotent stem cells.
Schopperle WM; Lee JM; Dewolf WC
Biochem Biophys Res Commun; 2010 Jul; 398(3):372-6. PubMed ID: 20599725
[TBL] [Abstract][Full Text] [Related]
16. Lonely death dance of human pluripotent stem cells: ROCKing between metastable cell states.
Ohgushi M; Sasai Y
Trends Cell Biol; 2011 May; 21(5):274-82. PubMed ID: 21444207
[TBL] [Abstract][Full Text] [Related]
17. Generation of CD34+ cells from CCR5-disrupted human embryonic and induced pluripotent stem cells.
Yao Y; Nashun B; Zhou T; Qin L; Qin L; Zhao S; Xu J; Esteban MA; Chen X
Hum Gene Ther; 2012 Feb; 23(2):238-42. PubMed ID: 21981760
[TBL] [Abstract][Full Text] [Related]
18. Total cellular glycomics allows characterizing cells and streamlining the discovery process for cellular biomarkers.
Fujitani N; Furukawa J; Araki K; Fujioka T; Takegawa Y; Piao J; Nishioka T; Tamura T; Nikaido T; Ito M; Nakamura Y; Shinohara Y
Proc Natl Acad Sci U S A; 2013 Feb; 110(6):2105-10. PubMed ID: 23345451
[TBL] [Abstract][Full Text] [Related]
19. Characterization of novel antibodies that recognize sialylated keratan sulfate and lacto-N-fucopentaose I on human induced pluripotent cells: comparison with existing antibodies.
Nakao H; Yamaguchi T; Kawabata K; Higashi K; Nonaka M; Tuiji M; Nagai Y; Toyoda H; Yamaguchi Y; Kawasaki N; Kawasaki T
Glycobiology; 2023 Mar; 33(2):150-164. PubMed ID: 36373215
[TBL] [Abstract][Full Text] [Related]
20. Comparative study using Raman microspectroscopy reveals spectral signatures of human induced pluripotent cells more closely resemble those from human embryonic stem cells than those from differentiated cells.
Tan Y; Konorov SO; Schulze HG; Piret JM; Blades MW; Turner RF
Analyst; 2012 Oct; 137(19):4509-15. PubMed ID: 22888493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
